ROYAL BANK OF CANADA - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 30 filers reported holding OBALON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$1,000
-90.9%
1,638
-78.1%
0.00%
Q1 2019$11,000
-26.7%
7,4910.0%0.00%
Q4 2018$15,000
-25.0%
7,4910.0%0.00%
Q3 2018$20,000
+25.0%
7,491
-2.2%
0.00%
Q2 2018$16,000
-38.5%
7,660
+2.4%
0.00%
Q1 2018$26,000
-91.5%
7,480
-83.8%
0.00%
Q4 2017$305,000
-65.7%
46,291
-50.3%
0.00%
Q3 2017$888,000
-2.1%
93,211
+1.9%
0.00%
Q2 2017$907,000
-1.0%
91,499
+6.7%
0.00%
Q1 2017$916,000
+39.2%
85,767
+15.4%
0.00%
Q4 2016$658,00074,2950.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 3,552,239$9,591,0004.68%
Tamarack Advisers, LP 2,100,000$5,670,0001.62%
Moisand Fitzgerald Tamayo, LLC 6,765$302,0000.17%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$892,0000.10%
HoyleCohen, LLC 114,650$310,0000.06%
Granite Investment Partners, LLC 77,511$210,0000.01%
C WorldWide Group Holding A/S 315,504$852,0000.01%
Cerity Partners LLC 20,686$56,0000.00%
Spark Investment Management LLC 18,300$49,0000.00%
HighTower Advisors, LLC 126,288$342,0000.00%
View complete list of OBALON THERAPEUTICS INC shareholders